Literature DB >> 9469843

In vitro gene transfer using human papillomavirus-like particles.

A Touze1, P Coursaget.   

Abstract

Recombinant papillomavirus-like particles have recently been shown to be highly effective for the prevention of papillomavirus infections and associated tumors, and a virus-like particle-based vaccine against the most prevalent HPV causing genital infection in humans will be developed in the near future. Another use of these virus-like particles may lie in gene therapy and DNA immunization. We report here that human papillomavirus-like particles composed of the major capsid protein (L1) of HPV-16 are able to package unrelated plasmid DNA in vitro and then to deliver this foreign DNA to eukaryotic cells with the subsequent expression of the encoded gene. The results indicate higher gene transfer than with DNA alone or with liposome. Virus-like particles are a very promising vehicle for delivering genetic material into target cells. Moreover, the preparation of the gene transfer vehicle is relatively easy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9469843      PMCID: PMC147398          DOI: 10.1093/nar/26.5.1317

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Cationic liposome-mediated transfection.

Authors:  P L Felgner; G M Ringold
Journal:  Nature       Date:  1989-01-26       Impact factor: 49.962

3.  Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.

Authors:  O Danos; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

Review 4.  Gene therapy: adenovirus vectors.

Authors:  K F Kozarsky; J M Wilson
Journal:  Curr Opin Genet Dev       Date:  1993-06       Impact factor: 5.578

5.  Amphiphilic peptides enhance the efficiency of liposome-mediated DNA transfection.

Authors:  H Kamata; H Yagisawa; S Takahashi; H Hirata
Journal:  Nucleic Acids Res       Date:  1994-02-11       Impact factor: 16.971

6.  Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells.

Authors:  P Le Cann; P Coursaget; S Iochmann; A Touze
Journal:  FEMS Microbiol Lett       Date:  1994-04-15       Impact factor: 2.742

7.  Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake.

Authors:  J C Perales; T Ferkol; H Beegen; O D Ratnoff; R W Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Transferrin-polycation conjugates as carriers for DNA uptake into cells.

Authors:  E Wagner; M Zenke; M Cotten; H Beug; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

9.  Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.

Authors:  R C Rose; W Bonnez; R C Reichman; R L Garcea
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  A novel integrin (alpha E beta 4) from human epithelial cells suggests a fourth family of integrin adhesion receptors.

Authors:  S Kajiji; R N Tamura; V Quaranta
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

View more
  36 in total

1.  DNA-induced structural changes in the papillomavirus capsid.

Authors:  C Fligge; F Schäfer; H C Selinka; C Sapp; M Sapp
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection.

Authors:  R B Roden; P M Day; B K Bronzo; W H Yutzy; Y Yang; D R Lowy; J T Schiller
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle.

Authors:  Sigrid C Holmgren; Nicole A Patterson; Michelle A Ozbun; Paul F Lambert
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 4.  Virus-like particles production in green plants.

Authors:  Luca Santi; Zhong Huang; Hugh Mason
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

Review 5.  Biological gene delivery vehicles: beyond viral vectors.

Authors:  Yiqi Seow; Matthew J Wood
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

Review 6.  Modern uses of electron microscopy for detection of viruses.

Authors:  Cynthia S Goldsmith; Sara E Miller
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

7.  Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.

Authors:  Simone Grasso; Luca Santi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-07-06

8.  Detection of human papillomavirus type 31-neutralizing antibodies from naturally infected patients by an assay based on intracellular assembly of luciferase-expressing pseudovirions.

Authors:  Maxime J J Fleury; Antoine Touzé; Silvia de Sanjosé; F Xavier Bosch; Joellen Klaustermeiyer; Pierre Coursaget
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

9.  Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies.

Authors:  Nicolas Combelas; Emilie Saussereau; Maxime J J Fleury; Tatiana Ribeiro; Julien Gaitan; Diego F Duarte-Forero; Pierre Coursaget; Antoine Touzé
Journal:  J Transl Med       Date:  2010-03-24       Impact factor: 5.531

10.  Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.

Authors:  B S Graham; R C Kines; K S Corbett; J Nicewonger; T R Johnson; M Chen; D LaVigne; J N Roberts; N Cuburu; J T Schiller; C B Buck
Journal:  Mucosal Immunol       Date:  2010-06-16       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.